Brian Elliott

Brian Elliott has a diverse work experience in the medical field. Brian is currently the VP Medical Head of the Epcoritamab Program at Genmab starting in November 2022. Prior to that, they were a Senior Medical Director at Genmab from December 2019 to November 2022. Brian also worked at Novartis as the Global Clinical Lead for Hematology from November 2016 to December 2019 and as a Medical Director and Associate Medical Director from January 2016 to November 2016 and October 2014 to December 2015, respectively. Before joining Novartis, they worked as a Hematologist-Oncologist at Mount Kisco Medical Group from November 2013 to October 2014. Brian's educational background includes a Hematology-Oncology Fellowship at Icahn School of Medicine at Mount Sinai from September 2011 to June 2013 and another Fellowship at University of Pennsylvania Health System from July 2010 to August 2011. Brian also served as an Internal Medicine Resident at The Mount Sinai Hospital from July 2007 to June 2010.

Brian Elliott attended Princeton University from 1999 to 2003, where they earned a Bachelor of Arts (BA) degree in Ecology and Evolutionary Biology. Following their undergraduate studies, they enrolled at Duke University School of Medicine from 2003 to 2007, where they completed their Doctor of Medicine (MD) degree. No specific field of study is provided for their MD degree.